Journal
CELL REPORTS
Volume 36, Issue 1, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2021.109339
Keywords
-
Categories
Funding
- NIH (NIAMS) [R01AR068974]
- NIH (NIAID) [R01AI042269]
Ask authors/readers for more resources
The decreased level of SRSF1 in T cells is associated with autoimmune diseases, as its absence leads to abnormal function of Treg cells, exacerbating inflammation and the development of autoimmune diseases.
The ability of regulatory T (Treg) cells to control the immune response and limit the development of autoimmune diseases is determined by distinct molecular processes, which are not fully understood. We show here that serine/arginine-rich splicing factor 1 (SRSF1), which is decreased in T cells from patients with systemic lupus erythematosus, is necessary for the homeostasis and proper function of Treg cells, because its conditional absence in these cells leads to profound autoimmunity and organ inflammation by elevating the glycolytic metabolism and mTORC1 activity and the production of proinflammatory cytokines. Our data reveal a molecular mechanism that controls Treg cell plasticity and offer insights into the pathogenesis of autoimmune disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available